Aberrant angiogenic signaling in HCC: therapeutic targeting and drug resistance

Aberrant angiogenic signaling in HCC: therapeutic targeting and drug resistance

Liver cancer ranks as the sixth most prevalent malignancy globally, with Hepatocellular Carcinoma (HCC) constituting the predominant subtype, thereby imposing a significant burden on public health and presenting limited therapeutic options. Despite ongoing efforts to innovate treatment modalities, a...

Full description

Saved in:
Bibliographic Details
Main Authors: Hongtao Zhang, Zhaoming Yang, Zhengwu Jiang, Zhijian Zhao, Xun Chen, Jian Wan, Yukun Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-06-01
Series:Frontiers in Oncology
Subjects:
hepatocellular carcinoma
angiogenesis
inhibitor
pathways
drug resistance
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1595195/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items